Company
Ambu
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
30
510(k), De Novo and PMA
Device trials
9
As lead sponsor, any status
Adverse event reports
90
Received Nov 1, 2025 to Nov 19, 2026
Recall records
22
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Ambu, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Ambu.
Latest FDA decisions
The 8 newest of 30 since 2015.
K260309 · Decided Sep 16, 2026 · 229 days after receipt
Device type: Bronchoscope (Flexible Or Rigid) (EOQ) · Otolaryngology (ENT)
K261400 · Decided Sep 16, 2026 · 140 days after receipt
Device type: Gastroscope And Accessories, Flexible/Rigid (FDS) · GI, Urology & Nephrology
K260578 · Decided Jul 14, 2026 · 144 days after receipt
Device type: Electrode, Cutaneous (GXY) · Neurology & Neurosurgery
K251583 · Decided Apr 30, 2026 · 342 days after receipt
Device type: Filter, Bacterial, Breathing-Circuit (CAH) · Anesthesiology & Respiratory
K250269 · Decided Jun 11, 2025 · 132 days after receipt
Device type: Cystoscope And Accessories, Flexible/Rigid (FAJ) · GI, Urology & Nephrology
K240849 · Decided Oct 16, 2024 · 203 days after receipt
Device type: Cystoscope And Accessories, Flexible/Rigid (FAJ) · GI, Urology & Nephrology
K240848 · Decided Oct 10, 2024 · 197 days after receipt
Device type: Cystoscope And Accessories, Flexible/Rigid (FAJ) · GI, Urology & Nephrology
K242108 · Decided Aug 16, 2024 · 29 days after receipt
Device type: Ureteroscope And Accessories, Flexible/Rigid (FGB) · GI, Urology & Nephrology
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
- AI-Guided Bronchoscopy Using the Broncho AI NavigatorPivotal-lookingRecruiting
NCT07944417 · 153 participants (planned) · Start Sep 14, 2026 · Primary completion May 30, 2027
Device: Broncho AI Navigator · For: Bronchoscopy
Sites: Odense, Denmark
- Effectiveness of Ambu® aScope™ 4 Cysto With the aView™ 2 Advance for Flexible CystoscopyPivotal-lookingCompleted
NCT04829461 · 102 participants · Start Apr 27, 2021 · Primary completion Jul 15, 2022
Device: Ambu® aScope™ 4 Cysto with the aView™ 2 Advance used for stent removal; Standard of care reusable cystoscope used for stent removal · For: Cystoscopy; Ureteral Stent
Sites: Hershey, Pennsylvania; Dallas, Texas; Madison, Wisconsin
NCT04628949 · 248 participants · Start Jan 25, 2021 · Primary completion Jan 27, 2022
Device: aScope™ Duodeno endoscope and aBox™ Duodeno · For: Endoscopic Retrograde Cholangiopancreatography (ERCP)
Sites: Birmingham, Alabama; Aurora, Colorado; Oak Lawn, Illinois · 9 sites in all
- Procedural Efficiency and Organisational Impact of Rhino Laryngoscopes Procedures in ConsultsStatus unknown
NCT05198219 · 50 participants (planned) · Start Jan 31, 2022 · Primary completion Apr 30, 2022
Device: Ambu® aScope™ 4 Rhinolaryngo; Conventional reusable rhinolaryngoscope · For: Laryngeal Disease
Sites: Ballerup Municipality, Denmark
- AuraOnce Performance ObservationCompleted
NCT04128527 · 16 participants · Start Oct 9, 2019 · Primary completion Nov 5, 2019
Device: Placement of laryngeal mask · For: Anesthesia
Sites: Copenhagen, Denmark
NCT04192474 · 83 participants · Start Jul 21, 2020 · Primary completion Apr 7, 2021
Device: Flexible cystoscopy · For: Cystoscope; Lower Urinary Tract Symptoms; Bladder Disease
Sites: Herlev, Denmark; Rotterdam, Netherlands
Reports received
90
Received Nov 1, 2025 to Nov 19, 2026. Includes 1 of another or unstated type.
Malfunction reports
33
37% of reports
Injury reports
50
56% of reports
Death reports
6
6.7% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 1 | 0 | 0 | 0 |
| Jan 24 | 1 | 2 | 0 | 0 |
| Feb 24 | 2 | 0 | 0 | 0 |
| Mar 24 | 2 | 0 | 0 | 0 |
| Apr 24 | 7 | 0 | 6 | 0 |
| May 24 | 5 | 2 | 0 | 0 |
| Jun 24 | 7 | 0 | 0 | 0 |
| Jul 24 | 0 | 3 | 4 | 0 |
| Aug 24 | 8 | 0 | 0 | 0 |
| Sep 24 | 1 | 0 | 2 | 0 |
| Oct 24 | 7 | 0 | 0 | 0 |
| Nov 24 | 9 | 2 | 0 | 0 |
| Dec 24 | 3 | 11 | 0 | 0 |
| Jan 25 | 2 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 1 | 2 | 0 | 0 |
| Apr 25 | 11 | 3 | 2 | 0 |
| May 25 | 1 | 2 | 0 | 0 |
| Jun 25 | 9 | 0 | 0 | 0 |
| Jul 25 | 2 | 5 | 2 | 1 |
| Aug 25 | 2 | 0 | 0 | 0 |
| Sep 25 | 2 | 4 | 0 | 0 |
| Oct 25 | 3 | 2 | 0 | 0 |
| Nov 25 | 4 | 4 | 0 | 0 |
| Dec 25 | 0 | 2 | 0 | 0 |
| Jan 26 | 2 | 0 | 0 | 0 |
| Feb 26 | 5 | 6 | 0 | 0 |
| Mar 26 | 1 | 0 | 0 | 0 |
| Apr 26 | 2 | 8 | 0 | 0 |
| May 26 | 7 | 4 | 0 | 0 |
| Jun 26 | 3 | 12 | 2 | 0 |
| Jul 26 | 1 | 4 | 0 | 0 |
| Aug 26 | 0 | 3 | 0 | 0 |
| Sep 26 | 0 | 5 | 0 | 0 |
| Oct 26 | 8 | 2 | 4 | 1 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2181-2025 · Started Jul 9, 2025 · Posted by FDA Aug 13, 2025
Reason given: Potential for the manometer port being blocked rendering the manometer non-functional.
Cause as FDA categorized it: Equipment maintenance · Device type: Ventilator, Emergency, Manual (Resuscitator) (BTM)
Z-1723-2025 · Started Apr 7, 2025 · Posted by FDA May 6, 2025
Reason given: Incorrect labeling in which the front red pouch label did not match the actual size of the medical device. The label on the front of the scope incorrectly states 5.0/2.2 while the back label, shipping box and product inside correctly states 5.6/2.8.
Cause as FDA categorized it: Process control · Device type: Bronchoscope (Flexible Or Rigid) (EOQ)
Z-0269-2025 · Started Sep 26, 2024 · Posted by FDA Oct 30, 2024
Reason given: Exceed the limitations to the 510 (k) exemption in 21 CFR 868.9(a) because it introduces a new indication for pediatric use in an Oropharyngeal Airway.
Cause as FDA categorized it: No Marketing Application · Device type: Airway, Oropharyngeal, Anesthesiology (CAE)
Z-0270-2025 · Started Sep 26, 2024 · Posted by FDA Oct 30, 2024
Reason given: Exceed the limitations to the 510 (k) exemption in 21 CFR 868.9(a) because it introduces a new indication for pediatric use in an Oropharyngeal Airway.
Cause as FDA categorized it: No Marketing Application · Device type: Airway, Oropharyngeal, Anesthesiology (CAE)
Z-0271-2025 · Started Sep 26, 2024 · Posted by FDA Oct 30, 2024
Reason given: Exceed the limitations to the 510 (k) exemption in 21 CFR 868.9(a) because it introduces a new indication for pediatric use in an Oropharyngeal Airway.
Cause as FDA categorized it: No Marketing Application · Device type: Airway, Oropharyngeal, Anesthesiology (CAE)
Z-0272-2025 · Started Sep 26, 2024 · Posted by FDA Oct 30, 2024
Reason given: Exceed the limitations to the 510 (k) exemption in 21 CFR 868.9(a) because it introduces a new indication for pediatric use in an Oropharyngeal Airway.
Cause as FDA categorized it: No Marketing Application · Device type: Airway, Oropharyngeal, Anesthesiology (CAE)
Z-0273-2025 · Started Sep 26, 2024 · Posted by FDA Oct 30, 2024
Reason given: Exceed the limitations to the 510 (k) exemption in 21 CFR 868.9(a) because it introduces a new indication for pediatric use in an Oropharyngeal Airway.
Cause as FDA categorized it: No Marketing Application · Device type: Airway, Oropharyngeal, Anesthesiology (CAE)
Z-0274-2025 · Started Sep 26, 2024 · Posted by FDA Oct 30, 2024
Reason given: Exceed the limitations to the 510 (k) exemption in 21 CFR 868.9(a) because it introduces a new indication for pediatric use in an Oropharyngeal Airway.
Cause as FDA categorized it: No Marketing Application · Device type: Airway, Oropharyngeal, Anesthesiology (CAE)
Showing the 8 newest of 22 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.